News Sentiment

BETA sentiment intelligence

BETA DRUGS LIMITED news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Weighted score 54 Balanced news tone 15 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 2366.80 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 15

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend active

+13.2% over one week, +33.6% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Beta Drugs completes Nivian Lifesciences acquisition

Market Reaction

Price moving ahead of tone

64/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 13.2% Price confirming higher
Trend fit Trend active 33.6% over four weeks
Fair value 54.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 12
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 15
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
scanx.trade 3
simplywall.st 2
Moneycontrol.com 2
The Economic Times 2
Equitypandit 1
HDFC Sky 1
Business Standard 1
CNBC TV18 1

Event Lens

What the news is about

Classified themes
Market update 9
Regulatory and legal 3
Deals and strategy 2
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-15 of 15
Equitypandit Direct company coverage

Beta Drugs Ltd

Tone
Neutral 50/100
Event
Market update
Published
10 Jan 2026 11:10
Source
Equitypandit